Skip to main content
Clinical Trials/NCT02004899
NCT02004899
Completed
Phase 3

Onset of Labor Epidural Analgesia With Low Dose Bupivacaine and Different Doses of Fentanyl: a Randomized Double Blinded Clinical Trial.

Lawson Health Research Institute1 site in 1 country105 target enrollmentDecember 2013

Overview

Phase
Phase 3
Intervention
Fentanyl
Conditions
Anesthetic, Sedative or Analgesic Complications in Labor or Delivery
Sponsor
Lawson Health Research Institute
Enrollment
105
Locations
1
Primary Endpoint
The time, in minutes, since completion of epidural bolus to the first painless contraction
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Epidural analgesia is the most effective form of labor pain relief. Low doses of local anesthetic (freezing solutions) in combination with opioids (narcotics) are commonly used as epidural solutions to provide pain relief. Low dose local anesthetic solutions with opioids for labor have been shown to decrease motor block (leg weakness or temporary paralysis), without affecting labor pain relief. However, onset of pain relief can be delayed with these low dose solutions. The standard epidural solution used at Victoria Hospital is a low dose of local anesthetic called bupivacaine mixed with fentanyl, an opioid, for labor epidural pain relief.

There is some evidence that the addition of more fentanyl to the epidural bolus dose of bupivacaine at the start of labor epidural analgesia can speed onset of pain relief. Both medications are safe for you and your baby.

This study will investigate whether the addition of different doses of fentanyl (20 mcg, 50 mcg and 100 mcg) to the epidural bolus dose speeds onset of pain relief.

The study hypothesis is that the onset of epidural labor analgesia will be shortest with the larger fentanyl epidural bolus.

Registry
clinicaltrials.gov
Start Date
December 2013
End Date
May 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Indu Singh

Associate Professor

Lawson Health Research Institute

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists (ASA) physical status 1 or 2
  • Pregnant women in early labor (cervical dilation \<5cm)
  • Singleton fetuses
  • Gestational age more than 36 weeks
  • Normal fetal heart rate tracing

Exclusion Criteria

  • Severe pre-ecclampsia
  • Antepartum hemorrhage
  • Chronic pain
  • Substance abuse
  • Language barrier between patient and investigator
  • Contraindications to epidural analgesia
  • Allergies to local anesthetics or fentanyl
  • Morbid obesity
  • Previous administration of opioid analgesia

Arms & Interventions

F20

Patients randomized to this arm of the study receive 20 mcg fentanyl and 8 mg bupivacaine as their epidural loading dose

Intervention: Fentanyl

F50

Patients randomized to this arm of the study receive 50 mcg fentanyl with 8 mg bupivacaine as their epidural loading dose

Intervention: Fentanyl

F100

Patients randomized to this arm of the study receive 100 mcg fentanyl and 8 mg bupivacaine as their epidural loading dose

Intervention: Fentanyl

Outcomes

Primary Outcomes

The time, in minutes, since completion of epidural bolus to the first painless contraction

Time Frame: Time since epidural bolus dose administration (At 1 and 5 minutes )

A painless contraction = verbal Numeric Pain Rating Scale less than or equal to 3/10

Secondary Outcomes

  • Sensory block height to ice(30 minutes after epidural bolus dose)
  • Time, in minutes, from epidural bolus dose to use of patient controlled epidural demand dose(Estimated time frame 1 hour)
  • Breastfeeding(24 hours after delivery)
  • Pruritis(30 minutes after epidural bolus dose)
  • Nausea(30 minutes after epidural bolus dose)
  • Maternal sedation(30 minutes after epidural bolus dose)
  • Hypotension(30 minutes after epidural bolus dose)
  • Motor block(30 minutes after epidural bolus dose)
  • Patient satisfaction of analgesia(30 minutes from epidural bolus dose)
  • Incidence of failed analgesia(30 minutes after epidural bolus dose)
  • Incidence of fetal bradycardia(Estimated time frame 24 hours)
  • Neonatal Apgar scores(At 1 and 5 minutes post-delivery)
  • Time, in minutes, from completion of epidural test dose to delivery(Estimated time frame 24 hours)
  • Type of delivery(Estimated time frame 24 hours)
  • Fetal birth weight(Estimated time frame 24 hours)

Study Sites (1)

Loading locations...

Similar Trials